Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants

By LabMedica International staff writers
Posted on 08 Jul 2026

Genomic surveillance is essential for detecting viral variants before they spread widely, yet many public health systems face high costs, uneven capacity, and computational barriers. More...

Existing analytic pipelines often struggle to scale across regions while preserving critical transmission links, slowing response during outbreaks. Lower-resource settings are disproportionately affected by these limitations. A new study shows a scalable algorithm that accelerates and lowers the cost of genomic surveillance.

Researchers at Texas A&M University developed the Iterative Block Particle Filter (IBPF), a computational framework designed to optimize global genomic surveillance. The framework aims to strengthen local, community-based sequencing capacity while preserving the regional interactions needed to track variant spread. The work was carried out with collaborators from multiple international institutions.

IBPF builds on the particle filter, also known as the Sequential Monte Carlo (SMC) method, which is widely used but hampered by the “curse of dimensionality” when applied to high-dimensional spatial networks. The new approach uses an iterative scheme in which the output from one data block becomes the input for the next, enabling localized updates without fragmenting critical connections between neighboring regions and travel hubs. By maintaining dependencies across spatial units while controlling filtering error locally, IBPF scales to high-dimensional spatiotemporal data common in pathogen surveillance.

In the study, the team implemented large-scale multi-strain models using real-world inputs, including epidemiological records, vaccine information, and high-resolution international air travel data. The framework tracked dozens of regions and multiple viral strains and outperformed common filtering algorithms. Notably, it reduced the time between detecting a disease variant and sequencing it. 

The results indicate that surveillance resources can be prioritized toward major international travel hubs, a strategy the authors note may be especially useful where long-term, large-scale sequencing efforts are not feasible. The paper, “Optimizing global genomic surveillance for early detection of emerging SARS-CoV-2 variants,” was published in Nature Communications.

Beyond COVID-19, the authors state that IBPF is compatible with more general systems and could support broader surveillance and forecasting applications. They also note the methodology’s relevance to other dynamic networks in which complex interactions evolve over time. The research group has made its code publicly available.

“In the machine learning community, many algorithms are designed to perform well only on specific test data sets. Our approach is different because we have theoretical performance guarantee that it works reliably across broad spatiotemporal data,” said Patricia Ning, assistant professor in the Department of Statistics at Texas A&M University.

“If we can optimize the allocation, we can spend money more efficiently. That would allow us to detect new variants much earlier without increasing the budget,” said Jifan Li, doctoral candidate in the Department of Statistics at Texas A&M University.

Related Links
Texas A&M University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.